ESC CONGRESS 2019

31 August - 04 September 2019, Paris - France

Session Details

Novel pharmacological targets in vascular disease Sat 31 Aug 09:00 - 10:30 Basic Science Advances in Science, Abstract-based Programme Pristina - Village 3 Chairpersons: Lina BADIMON (Barcelona, Spain), Iris BAUMGARTNER (Bern, Switzerland) Other resources List of Presentations Loading... Time   FP Nr   Title   Speakers   Related documents 09:00 53 State of the Art - Metabolic aspects of vascular disease Massimo FEDERICI (Rome, Italy) 09:18 54 Role of the gut microbiome for the cholesterol lowering effect of atorvastatin Friederike Luise ZIMMERMANN (, Germany) 09:36 55 Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension -high-throughput screening of 5,562 compounds- Ryo KUROSAWA (Sendai, Japan) 09:54 56 The SGLT2 inhibitor empagliflozin reduces mortality in experimental pulmonary hypertension Subodh VERMA (Toronto, Canada) 10:12 57 Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury Rhian TOUYZ (Glasgow, United Kingdom of Great Britain & Northern Ireland)